ECA Logo

In this section: 2017 Course

Course Outline

Swipe right on the table to view more...

Monday,
Oct. 16 2017
Tuesday,
Oct. 17 2017
Wednesday,
Oct. 18 2017
Thursday,
Oct. 19 2017
Friday,
Oct. 20 2017

08:30–09:00

Programme introduction

Dr Ignacio Anegon

Professor Reinhard Angelmar

Mr Andrew Hall 

                        

08:30–12:30

Valuation

Professor Bill Magill

08:30–12:30

Intellectual Property

Mr Pieter Wyckmans

 Mr Olivier Van Obberghen

08:30–12:30
Commercialisation options

Professor Paul Kewene-Hite

08:30–10:30
Business plan presentation preparation and dry runs

 

09:00–11:15
The biopharmaceutical industry and its environment

Professor Reinhard Angelmar

10:30–12:30
Group presentations

Prof. Paul Kewene-Hite

and other panel members incl. Dr. Sara Nunez-Garcia

11:30–13:00
The drug development process: from concept to CTA/IND

Dr Brydon Bennett

12:30–13:00
Conclusion

Professor Reinhard Angelmar

Lunch Lunch Lunch Lunch Lunch

14:00–16:30
The drug development process (continued)

Dr Brydon Bennett

14:00–16:15
What entrepreneurs in clinical academia should know about life science funding

Mr Lionel Carnot

13:30–15:00
Biopharmaceutical companies – academia collaborations

Mr Andrew Hall

13:30–18:00
Essentials of business planning

Business plan presentation preparation

Professor Paul Kewene-Hite

 

16:45–18:00
How I became an academic biotech entrepreneur

 Dr. Benjamin Owens

Dr. Jean-Loup Romet-Lemonne

 

16:30–18:00

Life Science 

Technology Commercialization at King's College London

Mr Michael Garrison

 

15:15–18:00
Biopharmaceutical companies - academia contracts 

Mr Pieter Wyckmans

 Mr Olivier Van Obberghen

 

 

 

 

19:00

Opening dinner

 

19:00

Cocktails at Danièle and Reinhard Angelmar’s home

Short speech by Prof. Carlo Pincelli:

Lessons of an academic entrepreneur

19:30

Closing dinner